or Try an Advanced Search...

    Technical Analysis for BPTH - Bio-Path Holdings Inc

    Grade Last Price % Change Price Change
    F 0.83 5.50% 0.04
    BPTH closed down 1.41 percent on Wednesday, November 20, 2024, on 1 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical BPTH trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 5.50%
    Wide Bands Range Expansion 5.50%
    Jack-in-the-Box Bearish Bearish Swing Setup 4.01%
    Narrow Range Bar Range Contraction 4.01%
    Wide Bands Range Expansion 4.01%
    Gapped Up Strength 4.01%
    New 52 Week Closing Low Bearish 10.79%
    Expansion Breakdown Bearish Swing Setup 10.79%
    Hammer Candlestick Bullish 10.79%
    New 52 Week Low Weakness 10.79%
    Older End-of-Day Signals for BPTH ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 5 hours ago
    10 DMA Resistance about 5 hours ago
    Up 5% about 5 hours ago
    Up 3% about 5 hours ago
    Up 2% about 5 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BPTH Chart by TradingView
    Basic chart:

    Profile

    Bio-Path Holdings, Inc., a biotechnology company, focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Its lead product candidate, Liposomal Grb-2, is in a Phase I study for blood cancers and in preclinical studies for triple negative and inflammatory breast cancers. The company's other drug candidate, Liposomal Bcl-2, is ready for the clinic where it would be evaluated in lymphoma and solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Houston, Texas.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Biotechnology Solid Tumors Acid Breast Cancer Lymphoma Cell Biology Treatment Of Breast Cancer Therapeutic Products Oncogenes Blood Cancers Apoptosis

    Is BPTH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Bio-Path Holdings, Inc. (BPTH) Q3 2024 Earnings Call Transcript
    Nov 15 Bio-Path: Q3 Earnings Snapshot
    Nov 15 Bio-Path GAAP EPS of -$0.70
    Nov 15 Bio-Path Holdings Reports Third Quarter 2024 Financial Results
    Nov 15 Earnings Scheduled For November 15, 2024
    Nov 14 Bio-Path Q3 2024 Earnings Preview
    Oct 9 Bio-Path Holdings Inc (BPTH) Q2 2024 Earnings Call Highlights: Financial Improvements and ...
    Oct 9 Bio-Path announces $4M private placement
    Oct 8 ACHR, BPTH, PLUG, REGRF:
    Oct 8 Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
    See more BPTH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.366
    52 Week Low 0.61
    Average Volume 1,476,584
    200-Day Moving Average 2.62
    50-Day Moving Average 0.97
    20-Day Moving Average 0.93
    10-Day Moving Average 0.85
    Average True Range 0.09
    RSI (14) 36.31
    ADX 24.85
    +DI 12.36
    -DI 30.02
    Chandelier Exit (Long, 3 ATRs) 0.86
    Chandelier Exit (Short, 3 ATRs) 0.89
    Upper Bollinger Bands 1.12
    Lower Bollinger Band 0.73
    Percent B (%b) 0.15
    BandWidth 42.56
    MACD Line -0.06
    MACD Signal Line -0.05
    MACD Histogram -0.0147
    Fundamentals Value
    Market Cap 9.73 Million
    Num Shares 12.4 Million
    EPS -2.00
    Price-to-Earnings (P/E) Ratio -0.39
    Price-to-Sales 0.00
    Price-to-Book 2.20
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.85
    Resistance 3 (R3) 0.84 0.82 0.84
    Resistance 2 (R2) 0.82 0.80 0.82 0.84
    Resistance 1 (R1) 0.80 0.79 0.79 0.81 0.83
    Pivot Point 0.78 0.78 0.77 0.78 0.78
    Support 1 (S1) 0.76 0.76 0.75 0.77 0.74
    Support 2 (S2) 0.73 0.75 0.74 0.74
    Support 3 (S3) 0.72 0.73 0.74
    Support 4 (S4) 0.73